News & Events

Anh Cong, a PhD student at the Mayo Clinic Graduate School of Biomedical Sciences, is studying the sister proteins targeted by anthracycline chemotherapy drugs, which are effective against many cancers but often leave patients with heart complications.

Texia Loh, a PhD student at Sanford Burnham Prebys Medical Discovery Institute, is researching strategies to enhance the effectiveness of treatment for small cell lung cancer.

Alina Ringaci, a PhD student at Boston University, is studying how to improve antibody-drug conjugates, a type of cancer treatment that delivers drugs directly to cancer cells.

In this PhRMA Foundation webinar, learn about the importance of patient engagement in value assessment and health outcomes research and how applicants for PhF awards can demonstrate their commitment to patient-centered research.

Do you have questions about the PhRMA Foundation’s grants and fellowships? Join our team for an informational webinar and Q&A session about our 2026 research funding opportunities.

In this webinar, we’ll share an overview of Pfizer’s postdoc program and how to apply, and current Pfizer fellows will discuss their experiences and answer questions.

The PhRMA Foundation and the American Society for Clinical Pharmacology and Therapeutics (ASCPT) announced today that six papers will receive Trainee Challenge Awards as part of a Clinical and Translational Science special call on artificial intelligence (AI) and machine learning (ML).

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. Fiona H. Marshall, PhD, President of Biomedical Research at Novartis, and Dr. Patrizia Cavazzoni, MD, Chief Medical Officer and Executive Vice President at Pfizer.

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello Crocetta, MD, MBA, Chief Medical Officer and Head of Medical Communities at UCB.